Merck & Co. MRK
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Merck & Co. (MRK) Business Model and Operations Summary
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Key Insights
Merck & Co. (MRK) Core Market Data and Business Metrics
Latest Closing Price
$86.6Market Cap
$218.75 BillionPrice-Earnings Ratio
12.85Total Outstanding Shares
2.53 Billion SharesTotal Employees
75,000Dividend
$0.81 Per Share QuarterlyIPO Date
April 20, 1949SIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
2000 Galloping Hill Road, Kenilworth, NJ, 07033
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 16,100,690 Shares | 2.31 | 3/14/2025 | 37,125,881 Shares |
| 16,829,624 Shares | 2.43 | 2/28/2025 | 40,943,400 Shares |
| 22,531,042 Shares | 1.43 | 2/14/2025 | 32,207,979 Shares |
| 12,570,208 Shares | 2.36 | 1/31/2025 | 29,603,048 Shares |
| 9,053,022 Shares | 3.77 | 1/15/2025 | 34,124,663 Shares |
| 10,511,424 Shares | 2.94 | 12/31/2024 | 30,926,600 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $-293 Million |
| Net Cash Flow From Financing Activities, Continuing | $-7.03 Billion |
| Net Cash Flow From Financing Activities | $-7.03 Billion |
| Net Cash Flow | $6.41 Billion |
| Net Cash Flow, Continuing | $6.70 Billion |
| Net Cash Flow From Investing Activities | $-7.73 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Gross Profit | $48.98 Billion |
| Costs And Expenses | $44.23 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Other Operating Expenses | $285 Million |
| Cost Of Revenue | $15.19 Billion |
| Income Tax Expense/Benefit | $2.80 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $216 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $17.33 Billion |
| Comprehensive Income/Loss | $17.33 Billion |
| Other Comprehensive Income/Loss Attributable To Parent | $216 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $28.42 Billion |
| Other Non-current Assets | $38.17 Billion |
| Fixed Assets | $23.78 Billion |
| Equity Attributable To Parent | $46.31 Billion |
| Accounts Payable | $4.08 Billion |
| Noncurrent Assets | $78.32 Billion |
Historical Dividends
Current dividend: $0.81 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 28, 2025 | Apr 7, 2025 | Mar 17, 2025 | $0.81 | Quarterly |
| Nov 19, 2024 | Jan 8, 2025 | Dec 16, 2024 | $0.81 | Quarterly |
| Jul 23, 2024 | Oct 7, 2024 | Sep 16, 2024 | $0.77 | Quarterly |
| May 28, 2024 | Jul 8, 2024 | Jun 17, 2024 | $0.77 | Quarterly |
| Jan 23, 2024 | Apr 5, 2024 | Mar 15, 2024 | $0.77 | Quarterly |
| Nov 28, 2023 | Jan 8, 2024 | Dec 15, 2023 | $0.77 | Quarterly |